Faculty And Planning Committee Disclosure Information

It is the policy of the University of Washington School of Nursing to ensure balance, independence, objectivity, and scientific rigor in all of its educational offerings. Speakers, authors, and planning committee members are required to disclose any financial or other relationships with a proprietary entity producing health care goods or services. Conflict of interest develops when an individual has an opportunity to affect educational content about the products or services of a commercial interest with which the individual has a financial relationship. The intent of this policy is to openly identify any such relationships so that a) UW Continuing Nursing Education can identify conflicts of interest which may have been created and b) learners can form their own opinions as to whether content reflects possible bias in exposition or conclusion. Speakers and authors are also required to disclose to participants when discussing off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration.

The following individuals disclosed the relationships described below.

Case Author Description of Relationship
Jo Hoffmann, MD Gilead: Advisory Committees or Review Panel
Jeanne Marrazzo, MD, MPH Gilead: Advisory Committees or Review Panel
John D. Scott, MD Genentech, Merck, Roche, Vertex: Grant/Research
Genentech, Gilead, Roche: Consulting, Speaking, Teaching
Vertex: Advisory Committees or Review Panel

The following individuals attest that they have no relationships to disclose.

Authors

  • Miriam J. Alter, Ph.D
  • Emily Darby, MD
  • Heike Deubner, MD
  • Linda Gorgos, MD, MSc
  • H. Nina Kim, MD
  • Brian J. McMahon, MD
  • Amit Singal, MD
  • Margaret C. Shuhart, MD, MS
  • David H. Spach, MD
  • David L. Thomas, MD
  • Chia Wang, MD

Planning Committee Member(s)

  • Bruce D. Maeder
  • Constance Hirnle, MN, RN